PGF and Hepatic fibrosis: Third, although this injection route delivers siRNA preferentially targeted to liver 39, 40, this is a challenging process and it is necessary to administer PlGF siRNA repeatedly for the continuous knockdown of PlGF mRNA in vivo in order to prevent the progression of hepatic fibrosis.